Status:
COMPLETED
Oxidative Stress and Hemodialysis Access Failure
Lead Sponsor:
National Institute of Environmental Health Sciences (NIEHS)
Collaborating Sponsors:
Leonard B Rosenberg Renal Research Foundation
Conditions:
End Stage Renal Disease
Hemodialysis
Eligibility:
All Genders
21+ years
Brief Summary
Complications of hemodialysis access are the most frequent single reason for hospitalization among patients with End Stage Renal Disease (ESRD). Uremia, and particularly uremia in patients with diabet...
Detailed Description
Patients continued their usual treatment on hemodialysis three times per week. This was a double-blinded placebo controlled trial. Patients took either Vitamin E 400 IU bid or placebo. An initial eval...
Eligibility Criteria
Inclusion
- Adults, end stage renal disease treated by hemodialysis, patent hemodialysis vascular access (graft or fistula)
Exclusion
- Temporary catheter dialysis access, inability to be compliant with study medication
Key Trial Info
Start Date :
May 1 2001
Trial Type :
OBSERVATIONAL
End Date :
May 1 2004
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT00410449
Start Date
May 1 2001
End Date
May 1 2004
Last Update
October 6 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for Dialysis Care
Cleveland, Ohio, United States, 44106